Anti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG Fc-glycosylation profiles that determine their clinical efficacy
Belinda M. Kumpel(NHS Blood and Transplant), Manfred Wuhrer(Leiden University Medical Center), Н. И. Оловникова, Radka Saldova(University College Dublin), Jodie L. Abrahams(Macquarie University), Gestur Vidarsson(Utrecht University), Agnes L. Hipgrave Ederveen(Leiden University Medical Center), Carolien A. M. Koeleman(Leiden University Medical Center), Pauline M. Rudd(St Bartholomew's Hospital), Kathryn L. Armour(University of Cambridge), Rick Kapur
Cited by 18
Related Papers
IgG Subclasses and Allotypes: From Structure to Effector Functions
|Frontiers in Immunology|2014|2.6k
Symbol Nomenclature for Graphical Representations of Glycans
|Glycobiology|2015|1.1k
High Throughput Isolation and Glycosylation Analysis of IgG–Variability and Heritability of the IgG Glycome in Three Isolated Human Populations
|Molecular & Cellular Proteomics|2011|533
Cell surface protein glycosylation in cancer
|PROTEOMICS|2013|518
Updates to the Symbol Nomenclature for Glycans guidelines
|Glycobiology|2019|486